85 results
Page 2 of 5
424B5
osgnth1
20 Nov 20
Prospectus supplement for primary offering
4:23pm
8-K
EX-99.1
g3p q80f375aip
22 Oct 20
Regulation FD Disclosure
1:14pm
8-K
EX-99.1
hyfzcwjbey2961 ir
30 Sep 20
Ovid Therapeutics Provides Soticlestat (OV935/TAK-935) Results from ARCADE and ENDYMION Studies Showing Seizure Reduction in Rare Epilepsies
8:05am
424B5
bh4lp 54l9y
26 Aug 20
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
bvhhn3i14n139x4yzn
25 Aug 20
Other Events
7:00am
8-K
EX-99.1
fh4qc6l332mrj7s0
17 Jun 20
Regulation FD Disclosure
1:11pm
8-K
EX-99.1
zi3dm nv4czva9v
7 May 20
Ovid Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
8:10am
8-K
EX-99.2
wd9fgvhyd52gny8ib
7 May 20
Ovid Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
8:10am
8-K
EX-99.1
urqdqr0
30 Mar 20
Ovid Therapeutics Announces Initial Data with Soticlestat in CDKL5 Deficiency Disorder and Dup15q Syndrome
8:05am